Erythema

DefinitionNLM MeSH D004890

Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.

Source: U.S. National Library of Medicine — MeSH (Erythema)

Drugs reporting Erythema (195)

Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.

1. 1Difamilast1100%
2. 2Picea Mariana Resin150%
3. 3Racepinephrine1537%
4. 4Cellulose133%
5. 5Hydroxyethyl Cellulose133%
6. 6Salicylic Acid12,31723%
7. 7Adapalene38,87021%
8. 8Sevabertinib120%
9. 9Ensulizole117%
10. 10Medronate117%
11. 11Trifarotene2816%
12. 12Hydroquinone17616%
13. 13Sulfur2,23115%
14. 14Octocrylene29813%
15. 15Avobenzone30212%
16. 16Aluminum Zirconium Tetrachlorohydrex Gly512%
17. 17Rna212%
18. 18Gadoterate Meglumine41412%
19. 19Cupric Oxide6411%
20. 20Benoxinate111%
21. 21Octisalate22411%
22. 22Dimethyl Sulfoxide2611%
23. 23Aluminum Chlorohydrate410%
24. 24Tirbanibulin239.9%
25. 25Iopromide3709.4%
26. 26Thioridazine59.4%
27. 27Mechlorethamine2109.4%
28. 28Meradimate19.1%
29. 29Benzylpenicilloyl Polylysine38.8%
30. 30Imiquimod1798.0%
31. 31Clocortolone28.0%
32. 32Delgocitinib147.8%
33. 33Aluminum Zirconium Trichlorohydrex Gly17.7%
34. 34Gadobutrol3687.7%
35. 35Iodixanol2577.5%
36. 36Palifermin287.2%
37. 37Monomethyl Fumarate657.2%
38. 38Titanium Dioxide257.1%
39. 39Procainamide177.1%
40. 40Iohexol5597.0%
41. 41Tazarotene906.7%
42. 42Aminolevulinic Acid1166.7%
43. 43Flutemetamol276.7%
44. 44Gadopiclenol146.7%
45. 45Spinosad36.7%
46. 46Asiatic Acid16.7%
47. 47Chloroxylenol76.6%
48. 48Sulfur Hexafluoride1156.5%
49. 49Tapinarof1096.5%
50. 50Mafenide26.5%
51. 51Desonide3086.4%
52. 52Naftifine216.3%
53. 53Zinc Oxide1986.3%
54. 54Oritavancin756.3%
55. 55Pyrithione356.2%
56. 56Vaborbactam36.1%
57. 57Clemastine785.9%
58. 58Florbetaben15.9%
59. 59Gluconolactone15.9%
60. 60Sertaconazole95.8%
61. 61Octinoxate215.8%
62. 62Sinecatechins35.7%
63. 63Motixafortide55.6%
64. 64Depemokimab15.6%
65. 65Deucravacitinib1495.5%
66. 66Fluocinolone2285.4%
67. 67Tetracaine335.4%
68. 68Ioversol2025.3%
69. 69Gadobenate2295.3%
70. 70Iodoquinol25.3%
71. 71Remimazolam55.2%
72. 72Ketoprofen6475.1%
73. 73Gadoteridol905.1%
74. 74Valerate3305.1%
75. 75Tuberculin1295.0%
76. 76Lebrikizumab684.9%
77. 77Dexchlorpheniramine494.9%
78. 78Meglumine4404.9%
79. 79Hypochlorite124.9%
80. 80Witch Hazel154.8%
81. 81Oxiconazole84.7%
82. 82Tretinoin4044.7%
83. 83Iothalamate44.7%
84. 84Olipudase Alfa54.5%
85. 85Homosalate444.5%
86. 86Histamine114.4%
87. 87Levomenthol44.4%
88. 88Dalbavancin504.4%
89. 89Pimecrolimus694.3%
90. 90Iomeprol534.3%
91. 91Amifostine344.2%
92. 92Ferumoxytol794.2%
93. 93Flavoxate44.0%
94. 94Cefprozil314.0%
95. 95Alclometasone123.9%
96. 96Pramlintide43.9%
97. 97Crisaborole3703.9%
98. 98Ivermectin2383.9%
99. 99Polidocanol523.8%
100. 100Velmanase Alfa23.7%
101. 101Oteseconazole13.7%
102. 102Pentetate13.7%
103. 103Podofilox43.7%
104. 104Perflutren2133.7%
105. 105Adenine23.6%
106. 106Ferric Derisomaltose443.6%
107. 107Cefadroxil683.5%
108. 108Nadolol2633.5%
109. 109Cupric Chloride253.5%
110. 110Factor Ix33.5%
111. 111Tralokinumab1923.5%
112. 112Oxybenzone243.5%
113. 113Iron Sucrose3203.5%
114. 114Crotamiton213.5%
115. 115Sulfacetamide253.5%
116. 116Sucrose3203.4%
117. 117Butenafine193.3%
118. 118Halobetasol493.3%
119. 119Cetylpyridinium213.3%
120. 120Sarecycline63.2%
121. 121Clobetasol3553.2%
122. 122Benznidazole33.2%
123. 123Ethynodiol53.2%
124. 124Alcaftadine283.1%
125. 125Halcinonide63.1%
126. 126Sofpironium63.1%
127. 127Fluocinonide1743.1%
128. 128Mupirocin4073.0%
129. 129Calcipotriene2013.0%
130. 130Sacrosidase53.0%
131. 131Luliconazole53.0%
132. 132Aluminum Chloride42.9%
133. 133Dupilumab12,5242.9%
134. 134Bacitracin1232.8%
135. 135Permethrin482.8%
136. 136Ertapenem1992.8%
137. 137Fluorescein252.8%
138. 138Cefixime802.8%
139. 139Panitumumab4102.8%
140. 140Bremelanotide242.7%
141. 141Pramoxine982.7%
142. 142Thiosulfate142.7%
143. 143Articaine212.7%
144. 144Remifentanil632.7%
145. 145Ciclopirox772.7%
146. 146Mepivacaine302.7%
147. 147Florbetapir32.7%
148. 148Mogamulizumab342.7%
149. 149Atrasentan22.7%
150. 150Iopamidol762.7%
151. 151Cefazolin3122.6%
152. 152Spesolimab92.6%
153. 153Capsaicin1002.6%
154. 154Sincalide42.6%
155. 155Vemurafenib3112.6%
156. 156Rezafungin22.6%
157. 157Carboxymethylcellulose3172.5%
158. 158Sodium Ascorbate792.5%
159. 159Clarithromycin8412.5%
160. 160Ascorbate792.5%
161. 161Camphor782.5%
162. 162Sulbactam632.5%
163. 163Enfortumab1592.4%
164. 164Clindamycin9052.4%
165. 165Tebentafusp132.4%
166. 166Donanemab482.4%
167. 167Sufentanil1522.4%
168. 168Amoxicillin2,3482.3%
169. 169Epinastine262.3%
170. 170Oxybutynin8312.2%
171. 171Deflazacort1382.2%
172. 172Paclitaxel2,1012.2%
173. 173Lapatinib3352.2%
174. 174Epoetin Beta2322.1%
175. 175Methoxy Polyethylene Glycol-epoetin Beta2322.1%
176. 176Nemolizumab2052.1%
177. 177Clascoterone292.1%
178. 178Alanine142.0%
179. 179Histidine142.0%
180. 180Isoleucine142.0%
181. 181Proline142.0%
182. 182Threonine142.0%
183. 183Leucine142.0%
184. 184Serine142.0%
185. 185Valine141.9%
186. 186Bexarotene251.9%
187. 187Sugammadex481.8%
188. 188Bimatoprost5131.8%
189. 189Avalglucosidase Alfa151.8%
190. 190Abrocitinib621.7%
191. 191Rocuronium1751.6%
192. 192Risankizumab1,1361.5%
193. 193Tetrofosmin81.3%
194. 194Ioflupane50.9%
195. 195Benzoyl Peroxide1,487—

Related reactions

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

• Urticaria59 shared · 0.21
• Hypersensitivity67 shared · 0.20
• Pruritus141 shared · 0.20
• Skin Exfoliation38 shared · 0.18
• Dry Skin40 shared · 0.18
• Rash140 shared · 0.15
• Anaphylactic Reaction31 shared · 0.13
• Skin Burning Sensation21 shared · 0.11
• Chills29 shared · 0.10
• Chest Discomfort26 shared · 0.10

Literature

Recent PubMed references pinned to Erythema as a MeSH major topic. About the reaction term itself — not about any specific drug.

• Integrating Pharmacogenomics and Network Topology for Machine Learning Prediction of HLA-Associated Severe Cutaneous Adverse Drug Reactions.
  International journal of molecular sciences · 2026 · Ponduan T, Kunsombut A, Paklao T, et al.
  PMID 42196169DOI 10.3390/ijms27104187
• The Effects of Nursing Care Applied in the Intensive Care Unit on a Case of Toxic Epidermal Necrolysis: A Case Report.
  Nursing in critical care · 2026 · Gulsoy Z, Özdemir Kol İ
  PMID 42132071DOI 10.1111/nicc.70513
• Beyond efficacy: pulse duration is crucial for adverse events in pulsed dye laser therapy for rosacea.
  The Journal of dermatological treatment · 2026 · Liu T, Liu Y, Meng X, et al.
  PMID 42112600DOI 10.1080/09546634.2026.2665064
• Case Report: Facial-limited eosinophilic annular erythema in a patient with rheumatoid arthritis: successful treatment with tofacitinib.
  Frontiers in immunology · 2026 · Wu MN, Wang Y, Bai YP, et al.
  PMID 42088487DOI 10.3389/fimmu.2026.1792217
• Efficacy and Safety of a Dual-Wavelength 589/1319 nm Laser for the Treatment of Acne Erythema: A Split-Face Randomized Controlled Trial.
  Journal of cosmetic dermatology · 2026 · Boonpethkaew S, Anansiripun P, Maitrisathit W, et al.
  PMID 42087432DOI 10.1111/jocd.70894
• Efficacy and Safety of Non-Cross-Linked Hyaluronic Acid Mesotherapy for Post-Acne Erythema: A Split-Face, Prospective, Randomized, Single-Center Trial.
  Journal of cosmetic dermatology · 2026 · Zhang D, Chang Y, Bai Y, et al.
  PMID 42087402DOI 10.1111/jocd.70813